Comparative cost-effectiveness of SARS-CoV-2 testing strategies in the USA: a modelling study
Du Z, Pandey A, Bai Y, Fitzpatrick MC, Chinazzi M, Pastore Y Piontti A, Lachmann M, Vespignani A, Cowling BJ, Galvani AP, Meyers LA. Comparative cost-effectiveness of SARS-CoV-2 testing strategies in the USA: a modelling study. The Lancet Public Health 2021, 6: e184-e191. PMID: 33549196, PMCID: PMC7862022, DOI: 10.1016/s2468-2667(21)00002-5.Peer-Reviewed Original ResearchConceptsLow transmission scenarioSARS-CoV-2 testing programSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Respiratory syndrome coronavirus 2SARS-CoV-2 transmissionSymptom-based testingSyndrome coronavirus 2Viral load dynamicsYLL avertedSARS-CoV-2 testing strategyTesting strategiesPositive test resultsCOVID-19 pandemicYears of lifeIsolation periodCoronavirus 2US National InstitutesViral testingPhysical distancing measuresEfficacious vaccineUS CentersAntiviral drugsIsolation durationEffective reproduction number